Clinical Trial Update: A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants [NA]

View source ↗

Summary

This entry updates the status of a completed clinical trial evaluating the safety and efficacy of the BD211 Drug Product in beta-thalassemia major.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• BD211 Drug Product

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: Hematologic Diseases | NA | Status: COMPLETED